PATH vs VERA
Uipath Inc (PATH) versus Vera Therapeutics Inc (VERA) — a side-by-side from cached financials, not a winner call.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Vera Therapeutics Inc (VERA) is a biotechnology company listed on NASDAQ.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
VERA does not have a complete income-statement cache yet.
PATH currently screens at market cap $6.07B and trailing P/E 19.4. VERA currently screens at market cap $2.51B.
Not investment advice. Open the PATH and VERA stock pages for the full models.
Not investment advice.